eMedicine Specialties > Pediatrics: Genetics and Metabolic Disease > Genetics

Noonan Syndrome

Author: Jennifer Ibrahim, MD, Fellow, Department of Pediatrics, Division of Genetics, Children's Hospital of New Jersey and Mount Sinai School of Medicine
Coauthor(s): Margaret McGovern, MD, PhD, Vice Chair, Professor, Department of Human Genetics, Mount Sinai School of Medicine
Contributor Information and Disclosures

Updated: Dec 12, 2007

Introduction

Background

Noonan syndrome was first recognized as a unique entity in 1963 when Noonan and Ehmke described a series of patients with unusual facies and multiple malformations, including congenital heart disease. These patients were previously thought to have a form of Turner syndrome, with which Noonan syndrome shares a number of clinical features. The observation that patients with Noonan syndrome have normal karyotypes was important in allowing the distinction to be made between the Turner and Noonan syndromes.

The cardinal features of Noonan syndrome are unusual facies (ie, hypertelorism, down-slanting eyes, webbed neck), congenital heart disease (in 50%), short stature, and chest deformity. Approximately 25% of individuals with Noonan syndrome have mental retardation. Bleeding diathesis is present in as many as half of all patients with Noonan syndrome. Skeletal, neurologic, genitourinary, lymphatic, eye, and skin findings may be present to varying degrees.

Pathophysiology

The pathophysiology of Noonan syndrome is not fully understood. Four disease causing genes (PTPN11, SOS1, RAF1, and KRAS) have been identified. All 4 genes are part of the RAS/RAF/MEK/ERKsignal transduction pathway, which is an important regulator of cell growth.

Frequency

United States

The incidence of Noonan syndrome is estimated to be 1 case per 1000 to 1 case per 2500 live births.

International

The incidence of Noonan syndrome appears to be consistent worldwide.

Mortality/Morbidity

The primary source of morbidity and mortality in these patients depends on the presence and type of congenital heart disease.

Race

Noonan syndrome is panethnic.

Sex

Noonan syndrome occurs in either a sporadic or autosomal dominant fashion. In either case, males and females are equally affected.

Age

The disorder is present from birth, but age impacts the facial phenotype. Infants with Noonan syndrome can be difficult to recognize by facial appearance alone. The phenotype becomes more striking in early childhood, but with advancing age, it may again become quite subtle. Careful examination of an affected child's parents may in fact reveal that they are mildly affected.

Clinical

History

The prenatal history is typically unremarkable; however, some cases are complicated by polyhydramnios, fetal edema, or cystic hygroma.

  • A careful family history should be obtained, paying particular attention to the presence of congenital heart disease, mental retardation, short stature, or unusual facies among the parents or siblings of an affected child.
  • A child with mild expression of the facial phenotype might only present with developmental delay and history of congenital heart disease. A history of abnormal bleeding is present in as many as 50% of patients.

Physical

  • Growth parameters
    • Size at birth is usually within the reference range.
    • Short stature is present in as many as 80% of patients. Average adult height for is 5 ft 5 inches in males and 5 ft in females.
  • Facial features
    • Triangular-shaped face
    • Hypertelorism
    • Down-slanting eyes
    • Ptosis
    • Strabismus (48%)
    • Amblyopia (33%)
    • Refractive errors (61%)
    • Low-set ears with thickened helices
    • High nasal bridge
    • Short webbed neck
  • Chest/back features
  • Cardiac features: The characteristic lesion is dysplastic/stenotic pulmonic valve, but virtually all types of congenital heart defects have been described in patients with Noonan syndrome. Hypertrophic cardiomyopathy (obstructive and nonobstructive types) is present in as many as 30% of patients.
  • Abdominal features: Hepatosplenomegaly unrelated to cardiac status is present in approximately 25% of patients.
  • Genitourinary features
    • Renal anomalies are present in 10% of patients but are not clinically significant.
    • More than half of male patients have undescended testes.
  • Skeletal features
    • Joint laxity is present in more than half of patients.
    • Talipes equinovarus, radioulnar synostosis, cervical spine fusion, and joint contractures are less common findings.
  • Skin findings
    • Lymphedema
    • Prominent pads of fingers and toes (67%)
    • Follicular keratosis of face and extensor surfaces (14%)
    • Multiple lentigines (3%)
  • Neurologic findings
    • Hypotonia
    • Seizure disorder (13%)
    • Unexplained peripheral neuropathy (infrequent)

Causes

Both sporadic and autosomal dominant cases have been identified. At least 4 disease-causing genes have been found.1,2,3,4,5

  • PTPN11 mutations account for approximately 50% of clinically recognized cases.
  • SOS1 mutations account for approximately 10% of cases.
  • RAF1 mutations account for 3-17% of cases.
  • KRAS mutations account for approximately 1% of cases.

More on Noonan Syndrome

Overview: Noonan Syndrome
Differential Diagnoses & Workup: Noonan Syndrome
Treatment & Medication: Noonan Syndrome
Follow-up: Noonan Syndrome
References
[ CLOSE WINDOW ]

References

  1. Tartaglia M, Kalidas K, Shaw A, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. Jun 2002;70(6):1555-63. [Medline].

  2. Tartaglia M, Pennacchio LA, Zhao C, et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet. Jan 2007;39(1):75-9. [Medline].

  3. Pandit B, Sarkozy A, Pennacchio LA, et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet. Aug 2007;39(8):1007-12. [Medline].

  4. Schubbert S, Zenker M, Rowe SL, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet. Mar 2006;38(3):331-6. [Medline].

  5. Carta C, Pantaleoni F, Bocchinfuso G, et al. Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype. Am J Hum Genet. Jul 2006;79(1):129-35. [Medline].

  6. Allanson JE. Noonan syndrome. J Med Genet. Jan 1987;DA - 19870320(1):9-13. [Medline].

  7. Allanson JE, Hall JG, Hughes HE, et al. Noonan syndrome: the changing phenotype. Am J Med Genet. Jul 1985;21(3):507-14. [Medline].

  8. Bader-Meunier B, Tchernia G, Mielot F, et al. Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr. Jun 1997;130(6):885-9. [Medline].

  9. Marino B, Digilio MC, Toscano A, et al. Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr. Dec 1999;135(6):703-6. [Medline].

  10. Noonan JA. Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am J Dis Child. Oct 1968;116(4):373-80. [Medline].

  11. Noonan JA. Noonan syndrome revisited. J Pediatr. Dec 1999;135(6):667-8. [Medline].

  12. Noonan JA. Noonan syndrome. An update and review for the primary pediatrician. Clin Pediatr (Phila). Sep 1994;33(9):548-55. [Medline].

  13. Qiu WW, Yin SS, Stucker FJ. Audiologic manifestations of Noonan syndrome. Otolaryngol Head Neck Surg. Mar 1998;118(3 Pt 1):319-23. [Medline].

  14. Sharland M, Burch M, McKenna WM, Paton MA. A clinical study of Noonan syndrome. Arch Dis Child. Feb 1992;67(2):178-83. [Medline].

  15. Sharland M, Morgan M, Smith G, et al. Genetic counseling in Noonan syndrome. Am J Med Genet. Feb 15 1993;45(4):437-40. [Medline].

  16. Singer ST, Hurst D, Addiego JE Jr. Bleeding disorders in Noonan syndrome: three case reports and review of the literature. J Pediatr Hematol Oncol. Mar-Apr 1997;19(2):130-4. [Medline].

  17. van der Burgt I, Thoonen G, Roosenboom N, et al. Patterns of cognitive functioning in school-aged children with Noonan syndrome associated with variability in phenotypic expression. J Pediatr. Dec 1999;135(6):707-13. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

Noonan syndrome, Noonan's syndrome, hypertelorism, down-slanting eyes, webbed neck, congenital heart disease, congenital heart disease, short stature, chest deformity, polyhydramnios, fetal edema, cystic hygroma, ptosis, strabismus, amblyopia, high nasal bridge, pectus carinatum, pectus excavatum, scoliosis, hepatosplenomegaly, talipes equinovarus, radioulnar synostosis, cervical spine fusion, lymphedema, LEOPARD syndrome, bleeding diatheses

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Jennifer Ibrahim, MD, Fellow, Department of Pediatrics, Division of Genetics, Children's Hospital of New Jersey and Mount Sinai School of Medicine
Jennifer Ibrahim, MD is a member of the following medical societies: American Society of Human Genetics
Disclosure: Nothing to disclose.

Coauthor(s)

Margaret McGovern, MD, PhD, Vice Chair, Professor, Department of Human Genetics, Mount Sinai School of Medicine
Margaret McGovern, MD, PhD is a member of the following medical societies: American Academy of Pediatrics and American Society of Human Genetics
Disclosure: Nothing to disclose.

Medical Editor

Elaine H Zackai, MD, Director of Clinical Genetics Center, Professor of Pediatrics, Department of Pediatrics, Division of Human Genetics and Molecular Biology, University of Pennsylvania, Children's Hospital of Philadelphia
Elaine H Zackai, MD is a member of the following medical societies: American College of Medical Genetics, American College of Phlebology, and American Society of Human Genetics
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Robert Anthony Saul, MD, Senior Clinical Geneticist, Greenwood Genetic Center; Clinical Professor, Department of Pediatrics, University of South Carolina
Robert Anthony Saul, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Nothing to disclose.

Chief Editor

Bruce Buehler, MD, Professor, Department of Pathology and Microbiology, Director, Hattie B Munroe Center for Human Genetics, Chairman, Department of Pediatrics, University of Nebraska Medical Center
Bruce Buehler, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Pediatrics, American Association on Mental Retardation, American College of Medical Genetics, American College of Physician Executives, American Medical Association, and Nebraska Medical Association
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.